C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/86 (2006.01) A61K 38/57 (2006.01) A61K 39/00 (2006.01) A61K 48/00 (2006.01) C07K 14/81 (2006.01) C12N 5/22 (2006.01) C12N 15/861 (2006.01) C12N 5/06 (2006.01)
Patent
CA 2499385
The present invention provides novel methods and means for influencing the CTL- sensitivity of antigen presenting cells such as dendritic cells upon viral infections. The invention provides novel gene delivery vehicles that are useful in different therapeutic settings such as vaccination and/or gene therapy.
La présente invention concerne de nouveaux procédés et moyens pour influencer la sensibilité aux lymphocytes T cytotoxiques de cellules de présentant de l'antigène telles que des cellules dendritiques, au cours d'infections virales. L'invention a également pour objet de nouveaux excipients d'administration génique qui ont différentes utilités thérapeutiques telles que la vaccination et/ou la thérapie génique.
Havenga Menzo Jans Emco
Kostense Stefan
Ophorst Olga Johanna Alberdina Elisa
Borden Ladner Gervais Llp
Crucell Holland B.v.
LandOfFree
Modified adenoviral vectors for use in vaccines and gene... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified adenoviral vectors for use in vaccines and gene..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified adenoviral vectors for use in vaccines and gene... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1724668